In the news
13
Oct

2025

Chris Spivey of PharmExec.com interviews ten23 Health CEO Hanns-Christan Mahler on understanding and managing risk in fill and finish manufacturing

This series, “The Situation We Faced,” is a CEO-type investigation interview into decision making, set within the context of other options, relative risk-reward situation, outcome and corporate culture ramifications, and market competitiveness positioning. So, sort of a war story reminiscence, but with clear technology or product context, some speculation about how other choices might have assisted or held things back.

As Hanns-Christian Mahler, CEO of Ten23 Health, explains the situation, “We saw up to 80% of the batch that had to be sorted out because of particulate defects in the final product, which eventually were clearly traceable to the primary packaging that was in use….

Please click here to read more


Locations
Sweden
United Kingdom
Switzerland
Denmark
France